Websites, domains, hosts that links to pfizerrxpathways.com
Our database shows, that the website pfizerrxpathways.com is linked by a total of 17 websites.
Number of websites/domains displayed: 17
Results found: 17
Websites discovered:
EFFEXOR XR® (venlafaxine HCl) | Safety Infohttp://pageoverview.com/website-report/effexorxr.com
Learn how EFFEXOR XR® (venlafaxine HCl) Choice Card can save eligible patients on the treatment of depression and certain types of anxiety disorders. Learn the risks and benefits of EFFEXOR XR.
- Expected expiration: November 15th in 2017
- Creation date: November 17th in 1997
- Renew date: October 14th in 2015
RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Infohttp://pageoverview.com/website-report/sutent.com
Learn about SUTENT® (sunitinib malate) for the treatment of advanced kidney cancer (RCC), GIST, and advanced pancreatic NET. See risks and benefits.
- Expected expiration: March 12th in 2018
- Creation date: March 12th in 2004
- Renew date: February 10th in 2016
- Google Analytics: 60148791-1
clinicians.org —http://pageoverview.com/website-report/clinicians.org
- Expected expiration: October 3rd in 2018
- Creation date: October 4th in 1996
- Renew date: March 12th in 2017
- Google Analytics: 18659136-1
Norvasc.com |http://pageoverview.com/website-report/norvasc.com
- Expected expiration: April 19th in 2018
- Creation date: April 18th in 1996
- Renew date: March 18th in 2016
AROMASIN® (exemestane tablets) Homehttp://pageoverview.com/website-report/aromasin.com
- Expected expiration: April 13th in 2018
- Creation date: April 13th in 1999
- Renew date: March 12th in 2016
Arthritis Treatment | CELEBREX® (celecoxib) Capsules | Safety Infohttp://pageoverview.com/website-report/celebrex.com
See risks and benefits. Learn about CELEBREX® (celecoxib) Capsules, a prescription treatment for arthritis symptoms and get the CELEBREX $4 Co-pay Card.
- Expected expiration: September 3rd in 2018
- Creation date: September 4th in 1998
- Renew date: August 2nd in 2016
Find Prescription Assistance | Pfizer RxPathwayshttp://pageoverview.com/website-report/pfizerrxpathways.com
Pfizer RxPathways connects patients to programs that offer insurance support, co-pay help, and medicines for free or at a savings.
- Expected expiration: April 10th in 2019
- Creation date: April 10th in 2013
- Renew date: March 9th in 2017
Revatio |http://pageoverview.com/website-report/revatio.com
- Expected expiration: March 7th in 2020
- Creation date: March 7th in 2000
- Renew date: February 3rd in 2018
Information for Healthcare Professionals | Pfizer Medical Information - UShttp://pageoverview.com/website-report/pfizermedicalinformation.com
Medical site for healthcare professionals to search for scientific info on Pfizer medications. Find the package insert, new information, resources, and channels to connect with Pfizer Medical.
- Expected expiration: July 19th in 2018
- Creation date: July 19th in 2005
- Renew date: June 18th in 2016
RELPAX® (eletriptan HBr) | Safety Infohttp://pageoverview.com/website-report/relpax.com
See risks and benefits. Learn more about how RELPAX® (eletriptan HBr) can help treat migraines with or without aura in adults.
- Expected expiration: April 23rd in 2018
- Creation date: April 24th in 1998
- Renew date: March 22nd in 2016
MDD Treatment | PRISTIQ® (desvenlafaxine)| Safety Infohttp://pageoverview.com/website-report/pristiq.com
Learn about PRISTIQ® (desvenlafaxine) for the treatment of major depressive disorder (MDD). See risks and benefits of PRISTIQ.
- Expected expiration: April 15th in 2018
- Creation date: April 15th in 2005
- Renew date: March 14th in 2016
Find Prescription Assistance | Pfizer RxPathwayshttp://pageoverview.com/website-report/phahelps.com
Pfizer RxPathways connects patients to programs that offer insurance support, co-pay help, and medicines for free or at a savings.
- Expected expiration: April 12th in 2019
- Creation date: April 12th in 2011
- Renew date: March 11th in 2017
Eczema Treatment | EUCRISA® (crisaborole) | Safety Infohttp://pageoverview.com/website-report/eucrisa.com
See risks and benefits of EUCRISA®, a topical prescription treatment for mild-to-moderate eczema (atopic dermatitis), for all skin tones in ages 2 & up.
- Expected expiration: July 26th in 2019
- Creation date: July 26th in 2011
- Renew date: February 17th in 2017
Rheumatoid Arthritis | XELJANZ® (tofacitinib citrate) | Safety Infohttp://pageoverview.com/website-report/xeljanz.com
XELJANZ® (tofacitinib citrate) is used to help treat adults with moderate to severe RA in which methotrexate did not work well. See risks & benefits of XELJANZ.
- Expected expiration: March 10th in 2019
- Creation date: March 10th in 2009
- Renew date: February 6th in 2017
Women Impacting Public Policyhttp://pageoverview.com/website-report/wipp.org
- Expected expiration: October 3rd in 2017
- Creation date: October 3rd in 2001
- Renew date: August 11th in 2015
- Google Analytics: 2449742-47